Foo J, Chmielecki J, Pao W, Michor F.2012.Effects of pharmacokinetic processes and varied dosing schedules on the dynamics of acquired resistance to erlotinib in EGFR-mutant lung cancer.Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.7(10):1583-93.Pubmed: 22982659DOI:10.1097/JTO.0b013e31826146ee
Foo J, Chmielecki J, Pao W, Michor F.2012.Effects of pharmacokinetic processes and varied dosing schedules on the dynamics of acquired resistance to erlotinib in EGFR-mutant lung cancer.Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.7(10):1583-93.Pubmed: 22982659DOI:10.1097/JTO.0b013e31826146ee
Franziska Michor uses the tools of theoretical evolutionary biology, applied mathematics, statistics, and computational biology to address important questions in cancer research.
